Veronica Santilli

Medicine & Life Sciences

1. Vaccination 100%
2. Child 61%
3. Vaccines 55%
4. B-Lymphocytes 53%
5. SARS Virus 48%
6. HIV 43%
7. Immunity 33%
8. Phosphatidylinositol 3-Kinases 33%
9. Immunization 31%
10. Kidney 30%
11. Coronavirus 30%
12. Premature Aging 30%
13. Highly Active Antiretroviral Therapy 29%
14. Influenza Vaccines 28%
15. Human Influenza 28%
16. Anti-Idiotypic Antibodies 28%
17. seletalisib 26%
18. Vaccine Immunogenicity 26%
19. Activated PI3K-delta Syndrome 24%
20. Preliminary Data 24%
21. Safety 23%
22. Lymphocyte Subsets 23%
23. HIV-1 23%
24. Severe Acute Respiratory Syndrome 21%
25. Epstein-Barr Virus Infections 20%
26. Transplants 19%
27. Immune System 19%
28. MF59 oil emulsion 18%
29. Burkitt Lymphoma 16%
30. Pediatrics 16%
31. Antibodies 15%
32. Lymphocytes 15%
33. Artificial Intelligence 14%
34. Haemophilus influenzae type b 14%
35. Rotator Cuff Injuries 14%
36. Pericarditis 14%
37. Human Herpesvirus 4 13%
38. Inactivated Vaccines 13%
39. Young Adult 13%
40. Natural Killer T-Cells 13%
41. Pediatric Hospitals 13%
42. Allergy and Immunology 13%
43. Population Density 12%
44. Rotator Cuff 12%
45. Measles 12%
46. DNA 12%
47. Histocompatibility Antigens Class II 12%
48. Cellular Senescence 12%
49. Rare Diseases 11%
50. Kidney Transplantation 11%